Viking Therapeutics stock is down 52% over the trailing-12-month period. However, many Wall Street analysts remain ...

The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...

Biotech is an area that may offer your portfolio growth today and earnings stability tomorrow. The idea is a biotech stock ...

Biotech stocks are among the few industry groups producing breakouts and buyable stocks in an uncertain market. Vertex stock ...

The Fed kept rates unchanged for now, a move that was widely expected. It did note, though, that “uncertainty around the ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to ...

This $2.5 billion investment reflects AstraZeneca's belief in "the world-class life sciences ecosystem in Beijing" and its ...

Learn more about whether Kymera Therapeutics, Inc. or Legend Biotech Corporation is a better investment based on AAII's A+ ...

Adaptive Biotechnologies (NASDAQ:ADPT) stock rises as Goldman Sachs upgrades to 'Buy,' citing an attractive end market. Read more here.

The meeting underscored the importance of leveraging both government initiatives and private sector capabilities to drive ...